TX-MAVENIR
11.1.2021 14:02:37 CET | Business Wire | Press release
Mavenir , the industry’s only end-to-end Network Software Provider and a leader in accelerating software network transformation for communications service providers (CSPs), has expanded and cloudified its Portfolio by announcing four new solutions: WebScale Platform, AI & Analytics, Multi-Access Edge Computing (MEC) and Digital Enablement Platform, all available today.
With cloud-native applications and technology innovation in the software space for mobile communications, consistent with Mavenir’s DNA, these solutions support the ongoing cloudification of the mobile networks, to enable CSPs to meet the growing data demands on their networks.
Mavenir’s cloud centric approach means moving applications to Commercial Off-The-Shelf (COTS) computing servers and embracing a complete ecosystem with applications in the Cloud (private, hybrid or public), which complement the basic Network Virtualized Functions (NVFs) and bring automation to improve the way operators manage and operate their networks.
In addition, this approach creates more flexibility and agility enabling the introduction of new services not only in the traditional consumer business, but also in the enterprise arena.
Webscale Platform: Suresh Somasundaram, SVP of 5G Cloud Platforms at Mavenir explains, “Mobile networks require digital transformation towards webscale platform technology that utilizes open source, Kubernetes platform as a service (PaaS). While a Kubernetes-based platform (PaaS) provides the foundation for fully automated life cycle management, it is built for mainly IT and enterprise applications and requires additional and specialized functions to support telecom and specifically, mobile workloads. To support those types of workloads, Mavenir has developed a common software extending standard opensource PaaS components to support telco needs for webscale deployment and to provide agile delivery of new applications expanding to Performance, Monitoring, Legal Intercept and Security. Mavenir’s WebScale Platform is the solution to give Mobile Operators the webscale agility of the Internet players.”
AI-powered Analytics : Kuntal Chowdhury, GM, AI & Analytics at Mavenir said, “With the cloudification and automation of the telecom networks, it becomes essential to utilize AI & Analytics solutions in a scalable platform combining real-time and big data analytics based on advanced Machine Learning algorithms. Mavenir’s AI & Analytics platform delivers extensive insights that are mandatory for WebScale network automation, slice management, security and many other use cases defined for the MEC (EdgeAI), RAN intelligence, traffic optimization and security. The AI/ML algorithms are defined with Mavenir’s deep telecom domain expertise, while keeping the interfaces standards-compliant & the platform open for collaborative innovation.”
Multi-access Edge Computing (MEC) : Ashok Khuntia, GM Cloud Packet Computing says, “Delivering low latency and high bandwidth at the edge of the network promises many exciting applications in 5G. Mavenir's optimized low-footprint data processing 5G Core platform enables mission critical MEC applications in the areas of Industrial automation, Augmented Reality/Virtual Reality, Gaming, Video surveillance, Autonomous driving and others. The additional focus on Multi-access Edge Computing (MEC) will accelerate such applications for many different industries and sectors.”
Digital Enablement: Sandeep Singh, GM, Digital Enablement at Mavenir noted, “Mavenir enables Operators and Enterprises to launch innovative value-based services faster to market with lower upfront investments in capital and time. Mavenir’s Digital Enablement Platform unlocks any network data, sources partner data, and serves up a value-added offering enriched through the platform’s flexible business control functions like Partner/Customer Management, Order Journey-Experience builder, Subscription/Usage Billing, Charging and Settlement. With the design focus on ‘adaptability’, the platform provides customers the agility and flexibility to experiment iteratively and deliver enhanced subscriber engagement experiences, ultimately benefitting in increased market reach and customer stickiness through new revenue generating services.”
“With a modern and secure Webscale platform as a foundation for edge computing, state of the art AI-based Analytics and Customer engagement solutions in our portfolio, Mavenir is a partner of choice for Telcos looking to offer new mission critical network edge solutions, transform network operations and business models for new 5G networks. In addition, Enterprises who need cost efficiency and customization in their connectivity and communication solutions will benefit,” said Bejoy Pankajakshan, Mavenir’s Chief Strategy Officer. “With a worldwide installed base and decades of experience in designing ‘Multi-G’ Telco services, Mavenir now offers its customer a path to realize the true potential of 5G through these new technology solutions.”
About Mavenir:
Mavenir is the industry's only end-to-end, cloud-native Network Software and Solutions/Systems Integration Provider, focused on accelerating software network transformation for Communications Service Providers (CSPs). Mavenir offers a comprehensive end-to-end product portfolio across every layer of the network infrastructure stack. From 5G application/service layers to packet core and RAN, Mavenir leads the way in evolved, cloud-native networking solutions enabling innovative and secure experiences for end users. Leveraging innovations in IMS (VoLTE, VoWiFi, Advanced Messaging (RCS)), Private Networks as well as vEPC, 5G Core and OpenRAN vRAN, Mavenir accelerates network transformation for more than 250+ CSP customers in over 120 countries, which serve over 50% of the world’s subscribers.
Mavenir embraces disruptive, innovative technology architectures and business models that drive service agility, flexibility, and velocity. With solutions that propel NFV evolution to achieve web-scale economics, Mavenir offers solutions to help CSPs with cost reduction, revenue generation, and revenue protection. mavenir.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210111005303/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4*12.11.2026 23:07:00 CET | Press release
The multi-level takeover includes a Throne Room, interactive photo opportunities, special lighting, and more The Empire State Building (ESB) is the gateway to Mount Olympus in Percy Jackson’s world, and now fans can experience the magic like never before. On Nov. 16, the Empire State Building Observation Deck (ESBOD) will unveil “Olympus Awaits,” a multi-level “Percy Jackson and the Olympians” takeover, in partnership with Disney+. The immersive takeover – included with every Observation Deck ticket – will feature an epic Throne Room, interactive photo opportunities, surprise giveaways, ESB x “Percy Jackson” merch, and more, available through Dec. 4, 2026.* This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112442266/en/ Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4* “This immersive NYC experience
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 18:09:00 CET | Press release
Veristat’s InStat™ delivers submission-ready tables, listings, and figures (TLFs) in one week using validated statistical engines, shortening the critical path from database lock to submission VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks
WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network12.11.2026 18:00:00 CET | Press release
New feature lets members follow friends and family, share performance and health insights, and celebrate life's moments together WHOOP, the human performance brand, today launched WHOOP Humans, a new feature that lets members follow friends and family, share fitness, health, and performance data they choose, and support each other's progress. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112176779/en/ WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network For more than a decade, WHOOP has helped members better understand their own health and performance. Now, WHOOP Humans extends that experience beyond the individual, making it easier to celebrate achievements, encourage progress, and look out for the people who matter most. "In a world that's becoming increasingly artificial, we're building something deeply human,” said Will Ahmed, Founder and CEO of WHOOP. “This is the most verifiably human network ever
Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 17:00:00 CET | Press release
International network will investigate fundamental principles for creating safer, higher-performing chemicals and materials The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and qua
Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 16:00:00 CET | Press release
Helping pharmaceutical manufacturers accelerate the journey from formulation to market through deep technical expertise, meaningful innovation, close collaboration and global capabilities Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical application
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom